DuPont de Nemours Inc. (DD) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

DuPont de Nemours Inc. (DD)

134.89

+0.72 (0.54%)

as of Jul 15, 2026, 7:59:58 pm Market Open.

50 watching

Investor Insights

Jul 15, 2026, 12:00 am

This summary was created by AI, based on 4 opinions in the last 12 months.

DuPont de Nemours Inc. is scheduled to report on Tuesday, and opinions regarding its future are mixed yet insightful. One expert mentions a recent parabolic move in the stock, suggesting cautiousness, while another praises the CEO's leadership in their successful sectors, such as water and materials. A significant consideration is the company's upcoming split into two separate entities, which could potentially unlock value, with predictions indicating a possible worth of $100 per share afterward. Experts agree that the individual components of the business are likely to perform better than the company as a whole, making this an enticing break-up narrative. Therefore, patience may be required as investors await the developments from the upcoming earnings report.

Consensus

Positive

Valuation

Undervalued

Similar

Bristol-Myers, BMY

TOP PICK

Roughly 26% of sales come from the agricultural area. More and more, this company will be recognized as a player in the seed and pesticide area. Also doing great things with solar and specialized materials.

TOP PICK

Have 5 major operating areas. Agriculture and pesticides is one of the key areas to earnings.

HOLD

Chemical stocks in general are acting extremely well. They are late cycle players. If you are a long-term investor, this would be a stock you could own.

TOP PICK

Next year will come out with a new line of seeds. Seed business has been "growing" and will continue to accelerate.

TOP PICK

A dynamic applied research and technology firm. Production of seeds for corn, soybeans etc, which is taking "off like a rocket" Doing some amazing things with the coatings and materials area.

TOP PICK

There will be a massive shift in the dietary habits of emerging markets. He now has a 16% exposure to agriculture in his portfolios. This is one of the world's great applied research technology companies.

TOP PICK

A leader in high tech and innovative research. Immediate attraction is the agricultural area. There is increased demand for protein based foods in the Far East. Dupont is producing a very hardy seed that will be rolled out next year.

TOP PICK

A world leader in research and innovation. Likes their work on seeds for improvement of productivity. Doing a lot of work with bio-butanol. This will be a long-term hold.

TOP PICK

This one is cheap with a great ROE of 20%-25% a year. Good debt to capitalization ratio. This company is one of the most exciting plays in terms of the biotech field.

BUY

Of the chemical companies, this is the one he would probably own. Have a life sciences division that is starting to come to the fore as a % of revenues. Also coming out with new high fibre products that are starting to add incrementally to their earnings.

COMMENT

A 5-year chart would show a lot of ups and downs. Right now, there is clear resistance developing where stocks globally relating to commodities have made their peaks. Risk/reward does not look too favourable. If you own, you may want to sell your stocks and buy call options. At the very minimum, you should trail up a stop or buy a put to protect against the downside.

COMMENT

Strong institutional buying which is why the multiple is higher. Trying to add more life sciences to their business so there are more growth expectations built into the stock. Been on a bumpy ride because feedstock prices have been all over the place. Check the whole group and for every $1 change of natural gas, what do the earnings do? Gives you a better idea for the long-term.

WEAK BUY

Have quite an array of diverse products. He has a small weighting of this in his fund.

WEAK BUY

They have exposure to the rising input costs. On the other hand, they are world class company. If you feel global growth will accelerate, particularly out of Japan, it should be a good play, otherwise you shouldn’t be there.

BUY

Risk reward prespective we are there. Support on a short term basis. Much below $35 would be worried. Look at long term ranges.

Showing 106 to 120 of 124 entries

Most Recent Experts

Colin Cieszynski

SIA Wealth Management

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Jim Cramer - Mad Money

CNBC

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Dan Rohinton

iA Global Asset Management

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

DuPont de Nemours Inc. (DD)